Business context and reporting period
Marathon Patent Group, Inc. (then formerly American Strategic Minerals Corporation) filed this Form 10-K for the fiscal year ended December 31, 2012. The company pivoted during the year from uranium and vanadium exploration, then real estate, to intellectual-property services and patent licensing and enforcement. It acquired Sampo IP LLC on November 14, 2012, and reported a portfolio of three U.S. patents and one pending application. The filing’s comparison is primarily against the period from the company’s April 30, 2011 inception through December 31, 2011—not a full prior fiscal year.
Financial performance and condition
| Metric | 2012 | Prior comparable period |
|---|---|---|
| Revenue from continuing operations | $0 | $0 |
| Operating expenses | $5.541 million | $9,848 |
| Net loss | $6.938 million; $6.928 million attributable to Marathon | $109,322 |
| Loss per share, basic and diluted | $0.19 | $0.01 |
| Cash from operating activities | $(1.261) million | $(29,348) |
- Discontinued operations recorded $724,090 of real estate revenue and $147,964 gross profit, but an overall loss of $1.411 million. The company reported no revenue from its patent business.
- 2012 expenses included approximately $2.4 million of stock-based compensation within compensation expense and approximately $1.8 million of stock-based consulting expense.
- At December 31, 2012, cash was $2.354 million, working capital approximately $2.4 million, total assets $4.017 million, and total liabilities $87,822. The balance sheet reported no notes payable at year-end.
- Cash used in investing activities was $1.861 million; cash provided by financing activities was $5.347 million, principally reflecting securities proceeds and payments on notes and a rescission agreement.
- Contractual obligations totaled $1.609 million, principally legacy uranium leases and minimum royalty payments, despite the decision to discontinue the minerals business.
Material changes versus the prior period
- Operating expenses increased to $5.541 million from $9,848; the comparison is affected by the short 2011 inception period and the company’s major change in business and capital structure.
- The company reported a $6.938 million net loss versus $109,322 in 2011, including a $1.411 million loss from discontinued operations and significant non-cash equity compensation.
- The Sampo acquisition involved $500,000 cash and 9.25 million shares. The company recorded the acquired net assets at $500,925, including the shares at par value, and disclosed that no independent valuation was performed.
- Cash rose from $129,152 at year-end 2011 to $2.354 million at year-end 2012, principally following equity financing. Shares outstanding reached 45,546,345 at year-end.
Outlook, risks, contingencies and unusual items
- Management did not anticipate significant revenue in 2013 and estimated available cash would cover current operating expectations for up to 12 months. It said future operations depended on additional financing; inability to raise funds could force curtailment or cessation of operations.
- The auditor and management identified substantial doubt about the company’s ability to continue as a going concern. The statements contain no adjustments for the outcome of that uncertainty. Management also cited expected proceeds from subsequent real estate disposals in its assessment of resources.
- Key risks include the absence of patent-business revenue and a limited operating history; reliance at the time on the Sampo portfolio; uncertain patent validity, enforceability and monetization; potentially lengthy and costly litigation; acquisition and financing risks; dilution; and thin OTC trading and stock-price volatility.
- Management concluded disclosure controls and internal control over financial reporting were ineffective at year-end, citing a limited internal audit function and insufficient segregation of accounting duties. It said material misstatements might not be prevented or detected timely.
- Related-party matters include the Sampo transaction involving the incoming CEO and CFO as former Sampo members, and consultant warrant awards and other transactions involving former officers, directors or associated parties. Review the disclosed terms and approvals.
- Other unusual items include a $1.256 million impairment of mineral rights, a $112,500 write-down of restricted California Gold securities, and the cancellation of 9,806,667 shares and 4.8 million warrants under a rescission agreement.
- Subsequent developments included the March 2013 launch of an IP research and services center, new executive appointments, and an agreement to acquire certain Augme Technologies assets and provide services. These developments do not establish that the new business had generated material revenue by the filing date.
Investor facts to verify
- Confirm the company’s actual cash runway, subsequent real estate sale proceeds, and financing needs against the going-concern disclosures.
- Review the Sampo patent portfolio’s ownership, remaining patent lives, independent valuation, and evidence of licensing demand or enforceability.
- Reconcile the $1.609 million contractual-obligation schedule with discontinued uranium operations and any termination or payment terms.
- Assess dilution from outstanding warrants, options, equity-plan reserves, and any subsequent issuances or registration-rights obligations.
- Check remediation of the disclosed ineffective controls and the status of related-party transactions and governance oversight.